Participant Name |
Role: Co-Chair/ CE Presenter / Moderator / Peer Reviewer |
Financial Disclosure for 24 Months (relationship is ongoing) |
Adeyemo, Adebowale |
GIM Open Editor |
Pending |
AlKuraya, Fowzan |
GIM Editor |
SAB: Neutrolis, Inc. Employee: Lifera Omerics |
Bennet, Robin |
GIM Editor |
No Relevant Financial Relationship |
Bombard, Yvonne |
GIM Open Editor |
Pending |
Brunetti-Pierri, Nicola |
GIM Open Editor |
No Relevant Financial Relationship |
Choy, Richard |
GIM Open Editor |
Pending |
Couser, Natario |
GIM Open Editor |
No Relevant Financial Relationship |
Cox, Allison |
GIM Editor |
No Relevant Financial Relationship |
Dhar, Shweta |
GIM Editor |
No Relevant Financial Relationship |
Drexler, Diane Dunham |
GIM Editor |
No Relevant Financial Relationship |
Duque-Lasio, Maria Laura |
GIM Editor |
No Relevant Financial Relationship |
Freeman, Peter |
GIM Open Editor |
No Relevant Financial Relationship |
Freeman, Peter |
GIM Editor |
No Relevant Financial Relationship |
Gambello, Michael |
GIM Editor |
No Relevant Financial Relationship |
Goddard, Katrina |
GIM Editor |
No Relevant Financial Relationship |
Hisama, Fuki |
GIM Open Editor |
DSMB: Larimar Therapeutics |
Koeberl, Dwight |
GIM Editor |
Consultant: AskBio, Bayer Pharmaceuticals DSB: Baxalta, Takeda Pharmaceuticals Patent: Bayer Pharmaceuticals |
Kozel, Beth |
GIM Editor |
No Relevant Financial Relationship |
Lazaro-Munoz, Gabriel |
GIM Editor |
No Relevant Financial Relationship |
Lansdon, Lisa |
GIM Editor |
No Relevant Financial Relationship |
Lebo, Matthew |
GIM Open Editor |
No Relevant Financial Relationship |
Levy-Lahad, Ephrat |
GIM Editor |
No Relevant Financial Relationship |
Li, Hong |
GIM Open Editor |
pending |
Li, Marilyn |
GIM Open Editor |
No Relevant Financial Relationship |
Lu, Qiongshi |
GIM Open Editor |
No Relevant Financial Relationship |
Miller, David |
GIM Editor |
Stock: Vertex Pharmaceuticals Inc. |
Mori, Mari |
GIM Editor |
No Relevant Financial Relationship |
Mvundura, Mercy |
GIM Editor |
No Relevant Financial Relationship |
Nathanson, Kate |
GIM Editor |
No Relevant Financial Relationship |
Ormond, Kelly |
GIM Open Editor |
No Relevant Financial Relationship |
Pereira, Stacey |
GIM Editor |
No Relevant Financial Relationship |
Porath, Binu |
GIM Editor |
Employee: Labcorp |
Rahm, Alanna |
GIM Editor |
pending |
Rasmussen, Sonja |
GIM Editor |
pending |
Rehder, Catherine |
GIM Editor |
Consultant: Alexion Pharmaceuticals, Amicus Therapeutics, Inc. |
Riggs, Erin |
GIM Open Editor |
Consultant: Illumina, Inc., Mirum Pharmaceuticals |
Rose, Nancy |
GIM Editor |
Consultant: BillionToOne, Inc. |
Schrodi, Steve |
GIM Editor |
Patents: Celera Corporation |
Scott, Stuart |
GIM Open Editor |
No Relevant Financial Relationship |
Shankar, Suma |
GIM Editor |
No Relevant Financial Relationship |
Smith, Hadley |
GIM Editor |
Consultant: Illumina, Inc. |
Steiner, Robert |
GIM Editor |
Consultant: Mirum Pharma; PTC Therapeutics; Ultragenyx Pharmaceuticals Employee: PreventionGenetics, subsidiary of Exact Sciences Patents: in newborn screening |
Stevenson, Dave |
GIM Editor |
Consultant: BioMarin; Novartis |
Stewart, Douglas |
GIM Editor |
No Relevant Financial Relationship |
Sutton, V.Reid |
GIM Editor |
Stock: Aceragen Speaker’s Bureau: Abbott Nutrition Consultant: Applied Therapeutics; Biomarin Pharmaceuticals; QED Therapeutics Grant: Ultragenyx Pharmaceutical, Inc. |
Tan, Wen-Hann |
GIM Open Editor |
Consultant: Baker Co.; Coactuate: Denali Therapeutics Inc. Research: F. Hoffman LaRoche Ltd.; Ionis Pharmaceuticals; Ultragenyx Pharmaceuticals |
Tarczy-Hornoch, Peter |
GIM Editor |
No Relevant Financial Relationship |
Webb, Bryn |
GIM Editor |
No Relevant Financial Relationship |
Wu, Ryanne |
GIM Editor |
Employee: 23andMe Consultant: MeTree&You |
Wu, Nan |
GIM Open Editor |
Grant: Illumina |
Yin, Xianyong |
GIM Editor |
No Relevant Financial Relationship |
Yuan, Bo |
GIM Open Editor |
Itellectual Property: UptoDate |